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background: The prevalence of sleep apnea (SA) is 5 to 10% in the general population. SA is associated with increased cardiac morbidity that can 
worsen the functional status of adult congenital heart disease (ACHD) patients. We hypothesized that ACHD patients have a higher prevalence of SA 
than the general population.
methods: We prospectively invited patients aged > 18 years attending an ACHD clinic to participate in this study. We administered the Epworth 
Sleepiness Scale (ESS), a validated, reproducible measure to screen patients. Total scores ≥ 11 are highly suggestive of SA. Patient demographics, 
comorbidities and cardiac history were obtained from medical chart review.
results: 126 patients have participated in the study and completed ESS surveys of whom 18 patients (14%) had been previously diagnosed with 
SA and 28 others (22%) had an elevated ESS Score. Statistical analysis was performed.
Patients with SA by diagnosis or ESS ≥ 11 (n = 46)
Patients without SA
(n =80 )
Male 27 33 NS
Female 19 47 NS
Mean age (years) 37.5 33.9 NS
Mean BMI 29.8 25.5 P=0.005
Mean oxygen saturation- 97 % 96% NS
Defect of moderate or great complexity 42 74 NS
Number of previous surgeries 1.6 (0-4) 1.8 (0-5) NS
Co morbidities 37 (80%) 60 (75%) NS
conclusions: Sleep apnea was observed in a third of ACHD patients and the prevalence is higher than in the general population. It is reasonable 
to consider including ESS screening as part of an ACHD evaluation given that:
(a) Sleep apnea is associated with other cardiac morbidities associated with decreased functional status in ACHD patients, and 
(b) Availability of treatment options.
Further, the finding that participants with higher BMIs appear to represent a particularly vulnerable sub-group of patients suggests yet another 
reason to promote healthy weights in this patient population.
